Neosynephrine (Phenylephrine Hydrochloride)

Phenylephrine is a selective α1‑adrenergic agonist. When applied intranasally, it binds to α1 receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This reduces mucosal edema and opens the nasal airway, easing breathing.

The appropriate dose of Neosynephrine is determined by a qualified healthcare professional based on the patient’s age, condition, and response. Users should follow the prescriber’s instructions or the product label for the recommended number of sprays per dose.

Safety data for phenylephrine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Neosynephrine to weigh potential benefits against any risks.

To order Neosynephrine, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neosynephrine’s phenylephrine is a sympathomimetic that provides rapid, short‑term decongestion similar to pseudoephedrine but with a lower systemic stimulant profile. Unlike oxymetazoline, phenylephrine has a shorter duration of action, which may reduce the risk of rebound congestion when used as directed.

Neosynephrine should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and discard any product that appears discolored or contaminated.

Neosynephrine is administered intranasally. The user gently inserts the spray tip into one nostril, closes the opposite nostril, and sprays the prescribed number of actuations while breathing in gently. The process is repeated in the other nostril if directed by the prescriber.

Serious risks, though uncommon, include severe hypertension, cardiac arrhythmias, and allergic reactions such as rash, swelling, or anaphylaxis. Individuals with uncontrolled high blood pressure, heart disease, or known hypersensitivity to phenylephrine should avoid use and seek medical advice promptly if symptoms arise.

Neosynephrine should not be used by people with known hypersensitivity to phenylephrine, uncontrolled hypertension, severe coronary artery disease, or by children under six years of age unless specifically advised by a healthcare professional.